Cannabis and anxiety in people and dogs: what the studies measure

Anxiety is not one outcome

CBD reduced anxiety during a public-speaking challenge in a small trial involving people with social anxiety. A later trial in people with high levels of worry found no improvement in persistent worry, although one repeated-treatment condition improved physical anxiety symptoms. In dogs, a separate study found a clearer cortisol difference during car travel than separation.

These studies used CBD; their results do not establish equivalent effects for THC or mixed cannabis products.

A small social-anxiety trial found an acute benefit

In a 2011 randomised, double-blind study, twenty-four previously untreated people with social anxiety disorder received CBD or placebo before a simulated public-speaking task. Twelve healthy participants formed an additional comparison group. CBD reduced anxiety, discomfort and reported cognitive impairment during the speaking task relative to placebo.

This is a concrete positive finding in a defined situation. It concerns a single experimental session in a small clinical sample. It does not tell us whether ordinary retail products produce the same result or whether the benefit persists during months of daily life.

Worry and physical symptoms responded differently

A 2023 placebo-controlled trial studied sixty-three people with elevated habitual worry, comparing two CBD conditions with placebo after an initial administration and over two weeks. Acute CBD did not improve worry severity or anxiety symptoms. Repeated administration did not reduce worry either; one CBD condition did reduce anxiety symptoms over the study period.

The investigators interpreted this as a possible modest effect on physical anxious arousal rather than the cognitive process of worrying. That distinction is practically important: feeling less physically tense and becoming less caught in repetitive anxious thoughts are not necessarily the same treatment outcome.

The dog study measured a stress challenge

A 2023 blinded, placebo-controlled study assigned forty dogs to CBD or placebo and exposed them to separation or car travel. Across the combined tests, post-test cortisol was lower in the CBD group. The difference was also significant for the car-travel group, but not for separation considered alone.

This gives a more precise account than saying CBD cured canine anxiety. The experiment examined responses to particular stressors, and not every measure or comparison showed the same pattern. A dog cannot describe worry verbally, so researchers combine physiological markers and observed behaviour; those measures should be interpreted together rather than treating quietness alone as recovery.

Results depend on the symptom

In the human studies, CBD reduced anxiety during a speaking challenge and some physical symptoms during repeated treatment, while persistent worry did not improve. In dogs, the cortisol difference was clearer during car travel than separation. The observed effects therefore concern specific symptoms and stress situations, rather than a uniform response across people and animals.